Advertisement
HLN vs OPTH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a StrongBuy and OPTH is a Hold.
HLN in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 29, 2026
HLN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 20 of 36 cases where HLN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 56%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HLN's RSI Oscillator exited the oversold zone, 14 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 52%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 25 of 47 cases where HLN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 53%.
Following a +5.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where HLN advanced for three days, in 140 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HLN as a result. In 40 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 54%.
The Moving Average Convergence Divergence Histogram (MACD) for HLN turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 18 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.
HLN moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HLN crossed bearishly below the 50-day moving average on November 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HLN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
The Aroon Indicator for HLN entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. HLN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.454) is normal, around the industry mean (6.379). P/E Ratio (24.973) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (2.158) is also within normal values, averaging (2.202). Dividend Yield (0.028) settles around the average of (0.062) among similar stocks. P/S Ratio (2.739) is also within normal values, averaging (183.387).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
OPTH's RSI Indicator dives oversold zone
The RSI Oscillator for OPTH moved into overbought territory on November 10, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 66 cases where OPTH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for OPTH just turned positive on November 10, 2026. Looking at past instances where OPTH's MACD turned positive, the stock continued to rise in 42 of 56 cases over the following month. The odds of a continued upward trend are 75%.
Following a +13.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPTH advanced for three days, in 172 of 201 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
OPTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for OPTH entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.760) is normal, around the industry mean (6.379). P/E Ratio (-1.164) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (135.135) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. OPTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPTH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
| HLN | OPTH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 52% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 53% | 2 days ago 82% |
| Momentum ODDS (%) | 2 days ago 54% | N/A |
| MACD ODDS (%) | 2 days ago 50% | 2 days ago 75% |
| TrendWeek ODDS (%) | 2 days ago 53% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 48% | 2 days ago 90% |
| Advances ODDS (%) | 8 days ago 53% | 7 days ago 86% |
| Declines ODDS (%) | 3 days ago 53% | 9 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 56% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 50% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HLN’s FA Score shows that 1 FA rating(s) are green while OPTH’s FA Score has 1 green FA rating(s).
- HLN’s FA Score: 1 green, 4 red.
- OPTH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HLN’s TA Score shows that 4 TA indicator(s) are bullish while OPTH’s TA Score has 5 bullish TA indicator(s).
- HLN’s TA Score: 4 bullish, 6 bearish.
- OPTH’s TA Score: 5 bullish, 2 bearish.
Price Growth
HLN (@Pharmaceuticals: Generic) experienced а +2.49% price change this week, while OPTH (@Pharmaceuticals: Generic) price change was +6.87% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.
Reported Earning Dates
HLN is expected to report earnings on Mar 04, 2027.
OPTH is expected to report earnings on Nov 13, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.20% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
HLN and
Correlation & Price change
A.I.dvisor indicates that over the last year, HLN has been loosely correlated with TAK. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then TAK could also see price increases.
| Ticker / NAME | Correlation To HLN | 1D Price Change % | ||
|---|---|---|---|---|
| HLN | 100% | +1.00% | ||
| TAK - HLN | 43% Loosely correlated | -0.76% | ||
| ZTS - HLN | 30% Poorly correlated | +0.17% | ||
| PBH - HLN | 28% Poorly correlated | +2.98% | ||
| LFCR - HLN | 27% Poorly correlated | N/A | ||
| AMRX - HLN | 26% Poorly correlated | +0.47% | ||
More | ||||
OPTH and
Correlation & Price change
A.I.dvisor tells us that OPTH and GELS have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPTH and GELS's prices will move in lockstep.
| Ticker / NAME | Correlation To OPTH | 1D Price Change % | ||
|---|---|---|---|---|
| OPTH | 100% | -9.80% | ||
| GELS - OPTH | 8% Poorly correlated | -6.12% | ||
| GLAS - OPTH | 6% Poorly correlated | +2.60% | ||
| AKAN - OPTH | 4% Poorly correlated | -8.85% | ||
| HLN - OPTH | 3% Poorly correlated | +1.00% | ||
| ALVO - OPTH | 3% Poorly correlated | +4.05% | ||
More | ||||